Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.
A team of international scientists has developed an an experimental direct-acting antiviral to treat COVID-19.
Griffith's cancer research has been acknowledged as among the best in the state by Cancer Council Queensland and rewarded with significant funding.
Griffith Health Institute
Associate Professor Nigel McMillan from Griffith University’s School of Medical Science has been awarded federal government funding to make further progress towards a human cure for the deadly Hendra virus. Since the first outbreak of the disease in 1994, there have been seven confirmed human cases in Australia, resulting in four deaths. Currently there are […]